This study evaluated the effects of elevated homocysteine (Hcy) on the oxidative stress response in retinal Müller glial cells. Elevated Hcy has been implicated in retinal diseases including glaucoma and optic neuropathy, which are characterized by retinal ganglion cell (RGC) loss. To understand the mechanisms of Hcy-induced RGC loss, in vitro and in vivo models have been utilized. In vitro isolated RGCs are quite sensitive to elevated Hcy levels, while in vivo murine models of hyperhomocysteinemia (HHcy) demonstrate a more modest RGC loss (∼20%) over a period of many months. This differential response to Hcy between isolated cells and the intact retina suggests that the retinal milieu invokes mechanisms that buffer excess Hcy. Oxidative stress has been implicated as a mechanism of Hcy-induced neuron loss and NRF2 is a transcription factor that plays a major role in regulating cytoprotective responses to oxidative stress. In the present study we investigated whether HHcy upregulates NRF2-mediated stress responses in Müller cells, the chief retinal glial cell responsible for providing trophic support to retinal neurons. Primary Müller cells were exposed to L-Hcy-thiolactone [50μM-10mM] and assessed for viability, reactive oxygen species (ROS), and glutathione (GSH) levels. Gene/protein levels of Nrf2 and levels of NRF2-regulated antioxidants (NQO1, CAT, SOD2, HMOX1, GPX1) were assessed in Hcy-exposed Müller cells. Unlike isolated RGCs, isolated Müller cells are viable over a wide range of Hcy concentrations [50 μM -1 mM]. Moreover, when exposed to elevated Hcy, Müller cells demonstrate decreased oxidative stress and decreased ROS levels. GSH levels increased by ∼20% within 24 h exposure to Hcy. Molecular analyses revealed 2-fold increase in Nrf2 expression. Expression of antioxidant genes Nqo1, Cat, Sod2, Hmox1, Gpx1 increased significantly. The consequences of Hcy exposure were evaluated also in Müller cells harvested from Nrf2 −/− mice. In contrast to WT Müller cells, in which oxidative stress decreased upon exposure to Hcy, the Nrf2 −/− Müller cells showed a significant increase in oxidative stress. Our data suggest that at least during early stages of Hhcy, a cytoprotective response may be in place, mediated in part by NRF2 in Müller cells.
Introduction
This study addresses the consequences in retinal Müller glial cells of exposure to excess homocysteine (Hcy). Hcy is an excitatory non-proteinogenic amino acid formed by the demethylation of methionine. It sits at the intersection of the remethylation and transsulfuration pathways (Ubbink et al., 1996; Selhub, 1999) . Enzymes involved in the remethylation pathway include methylene tetrahydrofolate reductase (MTHFR) and methionine synthase, which in the presence of folate and vitamin B 12 , convert Hcy to methionine used in DNA methyltransfer reactions. Enzymes involved in the transsulfuration pathway include cystathionine-β-synthase (CBS) and cystathionine-γ-lyase, which in the presence of vitamin B 6 form cysteine used to produce glutathione (GSH), hydrogen sulfide and taurine. Dietary deficiency of folate or B vitamins can lead to elevated plasma Hcy, a condition termed hyperhomocysteinemia (Hhcy) (Clarke et al., 1991; Jacques et al., 1996; Cantu et al., 2004) . Deficiency of the aforementioned enzymes is a common cause of Hhcy, with the most frequent mutation involving MTHFR (677 C→T) (Leclerc et al., 2005) . There is a significant association between Hhcy, neurodegenerative and cardiovascular diseases (Clarke et al., 1991; Boushey et al., 1995; Duan et al., 2002; Seshadri et al., 2002; Obeid and Herrmann, 2006; Religa et al., 2006) .
Retina is a neurovascular tissue prompting interest in the role of Hhcy in retinal disease (Ajith and Ranimenon, 2015) . Several studies implicate Hhcy in the pathogenesis of retinopathies involving retinal ganglion cells (RGCs) such as exfoliation glaucoma (Leibovitch et al., 2003; Bleich et al., 2004; Puustjarvi et al., 2004; Roedl et al., 2007) , which is the most common secondary form of glaucoma worldwide (Ritch, 1994) . The exact role of Hhcy in this disease, remains to be determined (Xu et al., 2012; Li et al., 2016; Pasquale et al., 2016) . In at least two murine models of Hhcy, there is significant reduction of RGCs and compromised visual function. In mice with deficiency of Mthfr, there is ∼20% loss of RGCs in mice at 24 wks, decreased NFL thickness and reduced positive scotopic threshold response . In mice with deficiency of Cbs, there is also ∼20% loss of RGCs and delayed visual evoked potentials in mice by 30 wks Yu et al., 2012) . Administration of Hcy intravitreally in rodents induces RGC loss, the severity of which is dose-dependent (Moore et al., 2001; Chang et al., 2011) .
Efforts to determine the mechanism by which Hhcy preferentially induces RGC loss have utilized primary RGC culture as a model system (Ganapathy et al., 2011a; Ganapathy et al., 20011b) . ∼50-60% of RGCs, purified by immunopanning, die within 18 h exposure to 50 μM Hcy-thiolactone (Dun et al., 2007) , whereas in the endogenous (in vivo) models, the loss of RGCs is more modest (∼20%). This observation suggests that in vivo there are cellular and molecular mechanisms that buffer excess Hcy and dampen the deleterious consequences of moderate Hhcy to RGCs. We hypothesize that retinal Müller cells play a role in this process. Müller cells are the principal retinal glial cells; they maintain homeostasis by providing trophic support to retinal neurons including RGCs (Bringmann et al., 2006 (Bringmann et al., , 2009 .
Evidence from studies of several cell types, including neurons, suggests that oxidative stress is a major mechanism by which Hhcy induces cellular damage (Kruman et al., 2000; Ho et al., 2001; Bhattacharjee et al., 2016) . In response to oxidative stress, Müller cells upregulate the gene encoding nuclear factor erythroid 2-related factor 2 (NRF2), which is an important antioxidant molecule that regulates transcription of more than 500 antioxidant/cytoprotective genes (Sporn and Liby, 2012; Gorrini et al., 2013 
Materials and methods

Animals, cell culture and Hcy treatment
C57Bl/6J mice were the source of retinal cells used in this study. The mice were the offspring of our breeding colony. Original breeding pairs, obtained from the Jackson Laboratories (Bar Harbor, ME), were maintained and their offspring utilized according to our IACUC approved protocol, which is consistent with the NIH guide for care and use of laboratory animals and complies with ARRIVE guidelines. Müller cells were also isolated from Nrf2 −/− mice, generated on the C57BL/6
background. Details about Nrf2 −/− mice have been described (Kaidery et al., 2013) . Isolation of Müller cells from P6-7 day old pups followed our published protocol (Jiang et al., 2006; Mysona et al., 2009; Wang et al., 2015) based on the method of Hicks and Courtois (1990) . The decision to isolate cells from mice at this age was based upon 3 H-thymidine labeling studies performed in mouse retina demonstrating the significant number of Müller cells present at this time period (Young, 1985) . Cells were used at passage 4-5. Earlier studies from our lab confirmed purity of the cells using this isolation method (Jiang et al., 2006; Mysona et al., 2009; Wang et al., 2015) and were repeated in the current study. Regarding primary RGCs, the isolation of cells was performed using retinas of mouse pups (P1-P5) following our published protocol (Dun et al., , 2007 (Dun et al., , 2008 Ganapathy et al., 2011a Ganapathy et al., , 2011b that is based upon a two-step immunopanning procedure (Barres et al., 1998) . The experiments were conducted on day 3 following isolation.
Treatment of cells with Hcy used L-homocysteine thiolactone hydrochloride. Hcy treatment stocks and dilutions were made fresh for each experiment. Hcy and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise specified.
Assessment of cell purity
Cells were seeded on coverslips and grown overnight. They were fixed with 4% paraformaldehyde, washed with PBS-Triton X-100, and (BioGenex, Fremont, CA) . Cells were incubated overnight at 4°C with primary antibodies to validate the identity of the primary Müller cell cultures (Hu et al., 2014) including vimentin, glutamine synthetase (GS), cellular retinaldehyde binding protein (CRALBP) (Table 1) . Additionally, they were incubated with primary antibodies that are specific for neurons (neuronal nuclei, NeuN) and retinal pigment epithelial cells (RPE65). RGC purity was confirmed using the neuronal marker Brn3a (Sajgo et al., 2017) (Table 1) . Cells were washed with PBS-Triton X-100 and incubated with the appropriate secondary antibodies (Table 1) for 1 h at 37°C. Cells were washed with PBS-Triton X-100 and mounted on slides using Fluoroshield with DAPI (4,6-diamidino-2-phenylindole, dihydrochloride) (Sigma-Aldrich) to label nuclei. Immunofluorescence images were obtained using either an Axioplan-2 fluorescent microscope (Carl Zeiss, Göttingen, Germany) equipped with an HRM camera or a Zeiss LSM 780 upright confocal microscope. Immunofluorescent images were processed using Zeiss Axiovision digital image processing software provided with the microscopes. Fluorescence intensity was quantified using ImageJ software (version 1.48, http://imagej.nih.gov/ ij/, NIH).
Assessment of cellular viability
The effects of Hcy on cell viability were assessed using PrestoBlue Viability reagent (Invitrogen, Carlsbad, CA). Cells were incubated 24 h in media containing [12.5-50 μM] Hcy for primary RGCs; [50μM-10mM] Hcy for primary Müller cells. Cells were then incubated 30 min in PrestoBlue reagent. The resazurin-based cell permeant dye penetrates viable cells and the reducing environment of these cells modifies the dye to yield a highly fluorescent red color. The fluorescence was detected using a plate reader (Molecular Devices, Sunnyvale, CA) at 570 nm excitation/590 nm emission.
Assessment of oxidative stress
Oxidative stress was detected in primary Müller cells using 2′,7' -dichlorofluorescein diacetate (DCFDA) (Abcam, Cambridge, MA). The cells were grown in black-sided, clear-bottom 96-well plates and incubated with DCFDA reagent [40 μM]. DCFDA is a cell permeant fluorogenic dye, which can detect hydroxyl, peroxyl and other reactive oxygen species (ROS) activity within cells. After 45 min incubation in DCFDA, cells were washed and treated with Hcy [50 μM-10 mM] for 3 h or 24 h. Cells were then subjected to fluorescence detection using a plate reader at 485 nm excitation/535 nm emission. Tertiary-butyl hydroperoxide (tBHP) [55 μM] treatment for 3 h was used as the positive control.
We confirmed these results using CellROX Green (Thermo Fisher Scientific, Waltham, MA), a cell permeant dye, which upon oxidation binds to DNA yielding a green fluorescent image; the signal localizes mainly to mitochondria and nuclei. Primary Müller cells were grown overnight on coverslips in 24 well plates. After Hcy treatment [50 μM-10 mM] for 3 h or 24 h, the medium was aspirated and cells were incubated 30 min with the CellROX reagent [5 μM], after which the dye was removed by aspiration, cells were washed with PBS and fixed with 4% paraformaldehyde (PFA, Electron Microscopy Science, Hatfield, PA). The coverslips were mounted on microscope slides using DAPI mounting medium and images were captured using the Zeiss LSM 780 upright confocal microscope. Fluorescence intensity was quantified using ImageJ software (NIH). As a positive control, Müller cells were exposed 30 min to 100 μM menadione, which increases ROS and reduces mitochondrial NADPH levels (Criddle et al., 2006) .
Assessment of intracellular GSH levels
We used the Glutathione (GSSG/GSH) Detection Kit (ADI-900-160, Enzo Life Sciences, Farmingdale, NY) to detect total, oxidized and reduced GSH in Hcy-treated primary Müller cells. Cells were grown in 6 well plates. After Hcy treatments [50 μm, 1 mM] for 24 h, cells were trypsinized, washed with PBS, and suspended in 5% (w/v) Metaphosphoric acid. After sonication, cell lysates were centrifuged. To the supernatant, glutathione reductase, provided in the kit, was added to reduce GSSG to GSH. The sulfhydryl group of GSH, thus formed, reacts with 5, 5′-dithiobis-2-nitrobenzoic acid (Ellman's reagent) to produce a yellow colored 5-thio-2-nitrobenzoic acid (TNB). The reaction kinetics was determined by measuring absorbance at 405 nm and readings were taken at 1 min intervals for 10 min. Serially diluted GSSG or oxidized glutathione was used to prepare a standard curve. Similarly, oxidized GSH or GSSG in the samples were detected by adding 4-vinyl pyridine, which blocks any free thiols present in the reaction. The absorbance readings were taken at 405 nm using a plate reader.
Assessment of gene expression
Müller cells were incubated with Hcy [50 μM, 1 mM] 3-20 h and were used to analyze genes involved in the Nrf2 antioxidant pathway (Nrf2, Hmox1, Nqo1, Cat, Sod2). RNA was prepared using Trizol (Invitrogen). 2 μg RNA was converted to cDNA using iScript Reverse Transcription Supermix (Bio-Rad Laboratories, Hercules, CA). Primer pairs used for the genes analyzed were obtained from Integrated DNA Technologies (Coralville, IA) and are listed in Table 2 qRT PCR was performed using SsoAdvanced SYBR Green Supermix from Bio-Rad (Hercules, CA) and the Bio-Rad CFX96-Real Time System Thermal Cycler (Hercules, CA). PCR was performed at 95°C for 10s and 56-57°C for 30s; melt curve analysis confirmed the purity of the end products. Relative mRNA levels were normalized to that of 18S. Expression levels were detected by comparing the Ct values (ΔΔCt) (Livak and 
Schmittgen, 2001). The analyses were performed in triplicate.
Assessment of protein levels
Cells were incubated with Hcy [50 μM, 1 mM] 3-20 h, after which they were lysed in a buffer containing 50 mM Tris HCl (pH 7.4), 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 1% SDS and 1x protease-phosphatase inhibitor cocktail (Thermo Fisher Scientific). 50-60 μg of protein were subjected to SDS polyacrylamide gel electrophoresis at 100 V and transferred to nitrocellulose membranes at 90 V for 1.5 h. Membranes were blocked in 5% milk in TBST (1 h RT) followed by incubation with primary antibodies (Table 1) in 5% milk in TBST buffer at 4°C overnight. Membranes were washed three times for 5 min in TBST and incubated with HRP-conjugated goat anti-rabbit or anti-mouse IgG antibody (Table 1) for 1 h at RT. The ECL Western blot detection system (Thermo Fisher Scientific) was used to visualize protein bands. Membranes were reprobed with anti-GAPDH (Millipore, Temecula, CA), which served as the loading control. To analyze nuclear versus cytoplasmic proteins, Müller cells were exposed to Hcy [50 μM, 1 mM] for 4 h. Proteins were extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) per the manufacturer's protocol. Fraction purity was confirmed using anti-HDAC1 and anti-GAPDH for the nuclear and cytoplasmic fractions, respectively (Table 1) . Protein band densities were quantified using ImageJ software and confirmed using Quantity One Software (Bio-Rad Laboratories). All immunoblot images represent three or more independent experiments.
Data analysis
The data were subjected to statistical analysis using Prism 6 for Windows Version 6.01 statistical analysis software (GraphPad, La Jolla, CA). All values are reported as mean ± SEM. Data were either analyzed by Kruskal-Wallis non-parametric test followed by Dunn's multiple comparison as the post-hoc test or were subjected to D'Agostino and Pearson Omnibus Normality test and then, as appropriate, either one-way ANOVA followed by Dunnett's test or two-way ANOVA (to compare multiple parameters) followed by Sidak's post-hoc comparison test. For all analyses p < 0.05 was considered statistically significant.
Results
Confirmation that primary RGCs are sensitive to Hhcy
Prior to investigating effects of excess Hcy on Müller glial cells, we confirmed the sensitivity of primary RGCs to Hhcy. Fig. 1A -C shows isolated RGCs, the cells are positive for the RGC marker Brn3 (Fig. 1A) and they are negative for the glial cell marker GFAP (Fig. 1B) . The neurite processes of the cells are visible by DIC microscopy (Fig. 1C) . RGCs were incubated with Hcy over a concentration range [12.5-50 μM] and viability was detected using PrestoBlue. Primary RGCs showed ∼40% cell death within 24 h exposure to 50 μM (Fig. 1D) . We then examined a shorter time period of Hcy exposure to determine whether there was a detectable increase in oxidative stress in RGCs incubated for only 3 h with increasing Hcy concentrations [25, 50, 100 μM] . Within 3 h there was a significant increase in DCFDA fluorescence in cells exposed to 100 μM Hcy (Fig. 1E) . The data confirm our previously published findings that primary RGCs are very sensitive to Hcy exposure leading to decreased viability and increased oxidative stress (Ganapathy et al., 2011a; Ganapathy et al., 20011b; Dun et al., 2007) .
Assessment of effects of Hhcy on primary Müller cell viability and oxidative stress
We followed our published procedure for isolating Müller cells from mouse retina (Jiang et al., 2006; Mysona et al., 2009; Wang et al., 2015) and confirmed the presence of known Müller cell markers glutamine synthetase (GS) ( Fig. 2A) , cellular retinaldehyde binding protein (CRALBP) (Fig. 2B) , and vimentin (Fig. 2C) in the cells. The isolated cells were negative for proteins not typically found in Müller cells (NeuN, a marker for neurons, Fig. 2D ; RPE65, a marker for retinal pigment epithelial cells Fig. 2E ). While the vulnerability of CNS neurons to high levels of Hcy is established (Mattson and Shea, 2003) , much less is known about how glial cells react to this excitotoxic amino acid.
We evaluated viability in Müller cells exposed to increasing concentrations of Hcy. Unlike the primary RGCs, which show a significant decrease in viability when exposed to 50 μM Hcy (Fig. 1D) , the primary Müller cells showed no change in viability following 24 h exposure to Hcy at a concentration range of 50 μM through 1 mM (Fig. 2F) . Only after the concentration of Hcy was extremely high, was there a significant effect on viability (e.g. 4 mM and 10 mM induced ∼40% and 90% cell death of Müller cells, respectively). These higher dosages [4 mM, 10 mM] far exceed physiological levels of Hcy, but the findings underscore the remarkable resilience of these retinal glial cells.
Oxidative stress is implicated as a mechanism by which Hhcy induces neuronal death (Lipton et al., 1997; Kruman et al., 2000; Mattson and Shea, 2003; Bhattacharjee et al., 2016) . We were interested in the role of Hcy in modulating oxidative stress in Müller glia. We used DCFDA to quantify the level of oxidative stress in the cells. Interestingly, in Müller cells we did not detect an increase in fluorescence in cells following 3 h exposure to Hcy, rather we observed a significant decrease in fluorescence in cells exposed to 50 μM Hcy, which decreased further in cells exposed to 100 μM and 500 μM Hcy (Fig. 2G) . We next exposed primary Müller cells for 3 h or 24 h to two concentrations of Hcy [50 μM or 1 mM] and used a second assay to detect oxidative stress, the CellROX green reagent. The reagent exhibits minimal fluorescence in the reduced state, but strong fluorescence in the oxidized state. We detected minimal fluorescence in cells exposed to Hcy [50 μM, or 1 mM] for 3 h (Fig. 2H ) or 24 h (Fig. 2I) , whereas cells exposed to menadione (a known oxidative stress inducer) showed robust fluorescence ( Fig. 2H and I) . The quantitative data from replications of the experiment are shown in Fig. 2J and K and indicate that at neither time point (3 or 24 h) nor concentration [50 μM or 1 mM] was there a significant increase in oxidative stress due to Hcy exposure.
Hhcy is associated with a robust antioxidant response in Müller glial cells.
The finding that oxidative stress was actually reduced, rather than increased, when Müller cells were exposed to Hhcy prompted investigation of several antioxidants. A key cellular antioxidant in retina is glutathione and the reduced form (GSH) attenuates ROS-induced cellular damage by reducing disulfide bonds. We used a commercially available kit to analyze levels of GSH in Müller cells exposed to 50 μM or 1 mM Hhcy for 24 h. The levels of total GSH increased in Hhcy-exposed Müller cells (Fig. 3A) and importantly the level of reduced GSH increased (Fig. 3B) . Whether expression of other antioxidant genes would be altered in Müller glia in the presence of excess Hcy was not known. To address this, we evaluated the consequences of Hhcy on expression of genes encoding heme oxygenase-1 (Hmox1), superoxide dismutase 2 (Sod2), catalase (Cat), glutathione peroxidase 1 (Gpx1) and NAD(P)H quinone dehydrogenase 1 (Nqo1) (Fig. 3C ). Cells were exposed to 50 μM or 1 mM Hcy for 3 h or 8 h, RNA was isolated and qRT-PCR performed with gene-specific primers (Table 2 ). There was an increase in expression of all of these genes, although the extent varied depending upon dosage and duration of exposure to Hcy. For example, levels of Hmox1 increased dramatically within 3 h exposure to 50 μM Hcy, but returned to baseline within 8 h exposure, whereas Sod2 expression did not differ significantly from control at 3 h, but was significantly increased at 8 h.
Hhcy upregulates Nrf2 in Müller glial cells
NRF2 is a transcription factor that regulates expression of numerous antioxidant genes including those analyzed in Fig. 3C . Given the increase in expression of these genes, we examined Nrf2 expression in Müller cells exposed to Hhcy. We used primers specific for Nrf2 in qRT-PCR analysis and quantified Nrf2 expression as a consequence of two Hcy concentrations and subsequently over a time course for one of these concentrations. The Hcy concentrations utilized were 50 μM and 1 mM; we observed upregulation of Nrf2 in Müller cells exposed 3 h to 50 μM Hcy and 1 mM Hcy (Fig. 4A) . We then explored the temporal changes in Nrf2 gene expression by exposing Müller cells to 50 μM Hcy for 1 h, 3 h, 6 h, 8 h and 18 h (Fig. 4B) . The most significant increase in Nrf2 levels occurred between 1 and 3 h exposure to Hcy and the peak increase in Nrf2 expression was at 3 h followed by a gradual return to baseline over the next 15 h. Interestingly, the increase in Nrf2 gene levels in Müller cells was not apparent at the protein level when we analyzed protein by western blotting in whole cell lysates. The immunodetection of bands for control cells (no Hcy exposure) and cells exposed to 50 μM Hcy for 3 h or 20 h is shown in (Fig. 4C) . Using anti-NRF2 antibodies, we detected two bands from the whole cell lysate, which is characteristic for detection of NRF2 as described by others (Macari and Lowrey, 2011; Ahuja et al., 2016) . Both bands were utilized to quantify the level of NRF2 as a ratio to GAPDH. We did not observe a statistically significant difference NRF2 levels in Hcy-treated versus non-treated cells (Fig. 4D) . This observation prompted analysis of NRF2 in nuclear versus cytosolic fractions. Typically cells maintain NRF2 at a basal level in the cytosol and excess NRF2 is degraded by the proteasome. Under stress however, increased NRF2 translocates from the cytosol to the nucleus. We isolated the nuclear and cytosolic fractions of Müller cells exposed to 50 μM or 1 mM Hcy. In the nuclear and cytosolic fractions, only one NRF2 band is typically observed for each fraction (Ahuja et al., 2016) . Nuclear and cytosolic NRF2 levels were quantified as a ratio to HDAC1 or GAPDH, respectively. There was a discernible increase in NRF2 in the nuclear fraction of cells exposed to 50 μM (∼59% increase) and 1 mM Hcy (65% increase) compared with the control cells, whereas NRF2 levels in the cytosol of Hcy-exposed Müller cells were decreased (50 μM: 17% decrease; 1 mM: 33% decrease) compared to controls (Fig. 4E) . Taken collectively, the data indicate that there is an increase in Nrf2 at the gene and protein level in Müller cells exposed to Hhcy, which may reflect an important cytoprotective response mechanism in these cells.
In the absence of NRF2, the antioxidant response to Hhcy is attenuated
Given that exposure of Müller cells to Hhcy triggers a robust antioxidant response characterized by increased expression of Nrf2, increased levels of NRF2 in the nuclear fraction, and upregulation of several antioxidant genes, we investigated the consequences of Hcy exposure in Müller cells lacking Nrf2. Müller cells harvested from Nrf2 −/− and WT mice were exposed to Hcy over a concentration range of 50 μM, 1 mM, 4 mM and 10 mM. WT cells showed minimal alteration in viability at 50 μM or 1 mM Hcy and a decrease in viability at 4 mM and 10 mM, similar to the data shown in Fig. 2 markedly (Fig. 5A) . We asked whether levels of oxidative stress differed between WT versus Nrf2 −/− Müller cells when exposed to Hhcy. As we observed in Fig. 2G , WT cells showed a decrease in DCFDA fluorescence when exposed to 50 μM and 1 mM Hcy compared to no Hcy treatment (control), however Nrf2 −/− Müller cells showed a significant increase in oxidative stress levels compared to WT (Fig. 5B ). There was a significant (∼50%) increase in DCFDA in non-Hcy-treated Nrf2
Müller cells versus WT cells (Fig. 5B) 3 . Assessment of glutathione and antioxidant genes in Müller cells exposed to Hhcy. Glutathione levels were detected in primary Müller cells exposed to 50 μM or1mM Hcy for 24 h as described in the text. Levels are shown for (A) total GSH, and (B) reduced GSH. n = 3, ***p < 0.001, ****p < 0.0001. (C) Expression of genes encoding several antioxidant proteins was analyzed by qRT-PCR in primary Müller cells exposed to 50 μM or 1 mM Hcy for 3 h or 8 h. n = 3, *p < 0.05, **p < 0.01, ***p < 0.001. (D'Agostino and Pearson Omnibus Normality test; data were normally distributed and were analyzed by one-way ANOVA and Dunnett's post-hoc test).
Discussion
This study was undertaken to investigate the effects of excess Hcy on retinal Müller glial cells. Accumulation of Hcy, a highly reactive amino acid, is implicated in retinal diseases (Ajith and Ranimenon, 2015) , notably those affecting RGCs in optic neuropathies such as exfoliation glaucoma (Ritch, 1994; Roedl et al., 2007) . Müller cells play a key role in maintaining RGCs, thus in the current study, we evaluated effects of Hcy in this glial cell type, specifically evaluating viability and response to oxidative stress.
We were particularly interested in the Müller cell response to Hhcy because of a conundrum observed in in vivo versus in vitro models of excess Hcy. Studies from two in vivo murine models of Hhcy, the Mthfr ± mouse and the Cbs ± mouse, both demonstrate ∼20% loss of RGCs over a 30-week period Markand et al., 2015) . While this loss is sufficient to alter retinal function in the mice, it is not blinding. In contrast, isolated (primary) RGCs are quite sensitive to Hcy such that ∼50-60% of the cells die when exposed 18 h to 50 μM Hcy (Dun et al., 2007; Ganapathy et al., 2011a Ganapathy et al., , 2011b ). An obvious and critical difference in the experimental systems is the in vivo models reflect the collective and potentially adaptive response of neurons and glia to Hcy-induced excitotoxicity, whereas in the in vitro studies, the primary RGCs are a purified neuronal population existing in a nutrientsupplemented, but nevertheless artificial milieu. We were interested in whether isolated Müller cells would also manifest a heightened sensitivity to Hcy when they were removed from their typical neuronalvascular-glial environment in a manner similar to isolated RGCs. The Hhcy-exposed primary Müller cells did not demonstrate heightened sensitivity to excess Hcy in vitro. They were viable over a broad range of Hcy exposure levels [50 μM-1 mM]. Müller cells demonstrated far more resilience to Hhcy exposure than primary RGCs. In addition, exposure of Müller cells to moderately elevated Hcy did not increase oxidative stress; rather oxidative stress actually decreased under Hhcy conditions. This result was confirmed using two different assays. The levels of oxidative stress decreased over a Hcy concentration range of [50 μM-1.0 mM], which was in contrast to primary RGCs in which oxidative stress increased markedly within 3 h exposure to 100 μM Hcy. Previous studies in Hhcy-exposed primary RGCs using electron paramagnetic resonance spectroscopy also detected marked oxidative stress including induction of reactive species superoxide, nitric oxide and peroxynitrite (Ganapathy et al., 2011a) . We conclude that while Hhcy increases oxidative stress dramatically in neurons such as RGCs, this is not the case in Müller cells.
The decreased oxidative stress observed in Müller cells prompted analyses of GSH levels and expression of several antioxidant genes. We detected a robust antioxidant response by Müller cells exposed to Hhcy. Reduced GSH, one of the most important scavengers of ROS, increased markedly in Müller cells exposed to Hhcy. This may represent a higher capacity to metabolize Hcy and is consistent with reports using HepG2 cells, which demonstrated an Hcy-induced dose-dependent increase in GSH . Expression of a number of antioxidant genes increased also in Müller cells exposed to Hcy compared to non-treated cells, including Hmox1, Sod2, Cat, Gpx1, Nqo1. NRF2, a redox-sensitive transcription factor that binds to antioxidant response elements located in the promoter region of these (and many other) genes, was elevated at the mRNA level. (Himori et al., 2013; Cho et al., 2015; Xu et al., 2015; Cheng et al., 2017; Wan et al., 2017) . It is recognized that Müller cells have a robust and remarkable capacity to buffer cellular stress (Bringmann et al., 2006) , although their activation in response may vary depending upon the disease (Hippert et al., 2015) . Some of the mechanisms by which Müller cells can attenuate oxidative stress (besides activation of Nrf2) or attenuate other forms of cellular stress include release of vascular endothelial growth factor (Yamada et al., 1999) , uptake of excess glutamate within the retina (Kawasaki et al., 2000) , and production of neurotrophic factors and growth factors (García and Vecino, 2003) . These were not examined in the present study, but could be fruitful areas of further investigation. In RGCs, the effects of homocysteine have been reported to be mediated by over activation of the N-methyl-D-aspartate receptor (NMDA) subtype of glutamate receptor (Lipton et al., 1997; Martin et al., 2004; Ganapathy et al., 2011b) , which can in turn lead to increased oxidative stress. There is considerable evidence that this is true for other non-retinal neuronal cell types as well (Bhatia and Singh, 2015; Sibarov et al., 2016) . Cortical glial cells are also known to express NMDA receptors (Dzamba et al., 2015) , however much less is known about the presence of NMDA receptors in mammalian retinal Müller glial cells, though they have been reported in Müller glia derived from chicken retina (Lamas et al., 2005) . Whether the differential sensitivity of the primary Müller cells versus primary RGCs to Hhcy observed in the present study reflects a difference in NMDA receptor activation remains to be investigated.
Our findings are relevant to in vivo models of Hcy in retinal disease. Earlier studies of endogenous murine models of Hcy (Mthfr ± and Cbs ± mice) showed clear evidence of RGC loss and diminished RGC function. However, compared to the effects of Hhcy on isolated RGCs, observed in this and other studies (Dun et al., 2007; Ganapathy et al., 2011a Ganapathy et al., , 2011b , the severity of the neuronal loss in the endogenous models was mild-moderate. This is intriguing. We speculate that Müller cells in these mouse models may be mounting a significant neuroprotective response to Hhcy. The present study, using the isolated Müller cell, supports this theory, i.e. Müller cells buffer effects of Hhcy, which may protect retinal neurons -at least for some time period. Our data suggest that the mechanism involves a robust antioxidant response. It is noteworthy that earlier studies performed in neural retinas of Mthfr ± and Cbs ± mice showed that, rather than being decreased, levels of GSH were similar to WT mice as were levels of xCT, a protein essential for the function of the cystine-glutamate exchanger involved in GSH synthesis (Cui et al., 2017) . Levels of antioxidants and NRF2 have not been investigated in Mthfr ± and Cbs ± mice, but this would also be an area of fruitful investigation in the future. The data obtained from the present study demonstrate a differential response to excess Hcy by glial cells versus neurons, one that is protective rather than deleterious -at least under acute conditions. The studies reflect a response to an insult spanning 24 h or less. In the rodent models, the exposure to the modest elevation of Hcy spans several weeks and the loss of the ganglion cells is gradual. In Mthfr −/− mice for example, RGC loss is detectable by 24 weeks, but not at 12 weeks. It may be that the capacity of Müller cells to buffer excess Hcy within the intact retina decreases with time. Long-term studies of these murine models at ages exceeding 1 year may disclose more advanced RGC loss.
The observations of the current study are relevant to humans, especially patients with exfoliation glaucoma. Hcy is modestly, but consistently higher in serum, aqueous humor and tears in patients with this disease (Roedl et al., 2007; Xu et al., 2012) . It is still unclear, however, whether Hcy is 'a disease driver, disease biomarker or an innocent bystander to some biochemical process related to Hcy metabolism' (Pasquale et al., 2016) . The present study does not answer this question, but it does provide insights that retinal cells respond differently to excess Hcyneurons in isolation demonstrate marked vulnerability and decreased viability, whereas glial cells in isolation demonstrate a robust antioxidant response coupled with sustained viability over a broad Hcy concentration range. Some of the confusion as to whether Hhcy is a marker for human retinal disease or is actually pathogenic may reflect varied responses by key supportive cells such as Müller cells. The work that we and others have performed in laboratory studies using in vitro and in vivo models provides compelling evidence that Hhcy can kill neurons and that glial cells can buffer the effects of Hhcy, at least for a period of time. If more clinical evidence continues to emerge that implicates Hhcy as a factor in RGC-related retinal diseases, there may be a benefit in modulating diet since increased folate consumption can decrease Hcy levels. It remains to be determined in controlled in vivo studies whether dietary modification would attenuate RGC loss, but such studies would be extremely informative as patient compliance with vitamin supplementation is certainly feasible.
